- Home
- STRT vs MREO Comparison
STRT vs MREO Comparison
Compare STRT & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRT
- MREO
- Stock Information
- Founded
- STRT 1908
- MREO 2015
- Country
- STRT United States
- MREO United Kingdom
- Employees
- STRT N/A
- MREO N/A
- Industry
- STRT Auto Parts:O.E.M.
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- STRT Consumer Discretionary
- MREO Health Care
- Exchange
- STRT Nasdaq
- MREO Nasdaq
- Market Cap
- STRT 282.6M
- MREO 286.4M
- IPO Year
- STRT 1995
- MREO N/A
- Fundamental
- Price
- STRT $75.30
- MREO $1.85
- Analyst Decision
- STRT
- MREO Strong Buy
- Analyst Count
- STRT 0
- MREO 5
- Target Price
- STRT N/A
- MREO $7.40
- AVG Volume (30 Days)
- STRT 58.4K
- MREO 1.3M
- Earning Date
- STRT 10-30-2025
- MREO 11-10-2025
- Dividend Yield
- STRT N/A
- MREO N/A
- EPS Growth
- STRT 45.55
- MREO N/A
- EPS
- STRT 5.73
- MREO N/A
- Revenue
- STRT $578,413,000.00
- MREO $500,000.00
- Revenue This Year
- STRT $3.31
- MREO N/A
- Revenue Next Year
- STRT $6.05
- MREO $72.16
- P/E Ratio
- STRT $13.12
- MREO N/A
- Revenue Growth
- STRT 6.83
- MREO N/A
- 52 Week Low
- STRT $31.57
- MREO $1.47
- 52 Week High
- STRT $83.00
- MREO $3.94
- Technical
- Relative Strength Index (RSI)
- STRT 61.92
- MREO 49.16
- Support Level
- STRT $63.49
- MREO $1.75
- Resistance Level
- STRT $67.99
- MREO $1.87
- Average True Range (ATR)
- STRT 3.87
- MREO 0.11
- MACD
- STRT 0.97
- MREO 0.00
- Stochastic Oscillator
- STRT 88.14
- MREO 67.86
About STRT STRATTEC SECURITY CORPORATION
Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).